125 related articles for article (PubMed ID: 11380511)
1. Effect of a series of novel sulphonylthioureas on glucose tolerance in the obese fa/fa Zucker rat.
Farrar NS; Chambers NJ; Carlsson AR; Denyer G; Johnston GA
Clin Exp Pharmacol Physiol; 2001; 28(5-6):386-91. PubMed ID: 11380511
[TBL] [Abstract][Full Text] [Related]
2. Influence of phytostanol phosphoryl ascorbate (FM-VP4) on insulin resistance, hyperglycemia, plasma lipid levels, and gastrointestinal absorption of exogenous cholesterol in Zucker (fa/fa) fatty and lean rats.
Wasan KM; Zamfir C; Pritchard PH; Pederson RA
J Pharm Sci; 2003 Feb; 92(2):281-8. PubMed ID: 12532378
[TBL] [Abstract][Full Text] [Related]
3. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
4. Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats.
Liu YL; Sennitt MV; Hislop DC; Crombie DL; Heyman RA; Cawthorne MA
Int J Obes Relat Metab Disord; 2000 Aug; 24(8):997-1004. PubMed ID: 10951538
[TBL] [Abstract][Full Text] [Related]
5. Effects of stevioside on glucose transport activity in insulin-sensitive and insulin-resistant rat skeletal muscle.
Lailerd N; Saengsirisuwan V; Sloniger JA; Toskulkao C; Henriksen EJ
Metabolism; 2004 Jan; 53(1):101-7. PubMed ID: 14681850
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.
Alemzadeh R; Fledelius C; Bodvarsdottir T; Sturis J
Metabolism; 2004 Apr; 53(4):441-7. PubMed ID: 15045689
[TBL] [Abstract][Full Text] [Related]
7. Lifelong sequential changes in glucose tolerance and insulin secretion in genetically obese Zucker rats (fa/fa) fed a diabetogenic diet.
Fürnsinn C; Komjati M; Madsen OD; Schneider B; Waldhäusl W
Endocrinology; 1991 Feb; 128(2):1093-9. PubMed ID: 1989847
[TBL] [Abstract][Full Text] [Related]
8. Development of glucose intolerance in obese (fa/fa) Zucker rats.
Apweiler R; Freund P
Horm Metab Res; 1993 Oct; 25(10):521-4. PubMed ID: 8262460
[TBL] [Abstract][Full Text] [Related]
9. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of insulin resistance in genetically obese rodents by M16209, a new antidiabetic agent.
Murakami N; Ohta M; Hashimoto K; Kato K; Mizota M; Miwa I; Okuda J; Inoue G; Kuzuya H; Nakao K; Imura H
Eur J Pharmacol; 1996 May; 304(1-3):129-34. PubMed ID: 8813594
[TBL] [Abstract][Full Text] [Related]
11. The effects of gonadectomy on glucose tolerance of genetically obese (fa/fa) rats: influence of sex and genetic background.
Kava RA; West DB; Lukasik VA; Wypijewski C; Wojnar Z; Johnson PR; Greenwood MR
Int J Obes Relat Metab Disord; 1992 Feb; 16(2):103-11. PubMed ID: 1316324
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of Prosopis glandulosa as antidiabetic treatment in rat models of diabetes and insulin resistance.
George C; Lochner A; Huisamen B
J Ethnopharmacol; 2011 Sep; 137(1):298-304. PubMed ID: 21645608
[TBL] [Abstract][Full Text] [Related]
13. Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively with Sulfonylureas.
Ito R; Tsujihata Y; Suzuki M; Miyawaki K; Matsuda K; Takeuchi K
J Pharmacol Exp Ther; 2016 Apr; 357(1):217-27. PubMed ID: 26813930
[TBL] [Abstract][Full Text] [Related]
14. Effects of BRL 26830, a novel beta-adrenoceptor agonist, on glucose tolerance, insulin sensitivity and glucose turnover in Zucker (fa/fa) rats.
Smith SA; Levy AL; Sennitt MV; Simson DL; Cawthorne MA
Biochem Pharmacol; 1985 Jul; 34(14):2425-9. PubMed ID: 2861816
[TBL] [Abstract][Full Text] [Related]
15. Metformin causes reduction of food intake and body weight gain and improvement of glucose intolerance in combination with dipeptidyl peptidase IV inhibitor in Zucker fa/fa rats.
Yasuda N; Inoue T; Nagakura T; Yamazaki K; Kira K; Saeki T; Tanaka I
J Pharmacol Exp Ther; 2004 Aug; 310(2):614-9. PubMed ID: 15039452
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats.
Liu X; Pérusse F; Bukowiecki LJ
Am J Physiol; 1998 May; 274(5):R1212-9. PubMed ID: 9644032
[TBL] [Abstract][Full Text] [Related]
17. The male obese Wistar diabetic fatty rat is a new model of extreme insulin resistance.
Greene SF; Johnson PR; Eiffert KC; Greenwoodt MR; Stern JS
Obes Res; 1994 Sep; 2(5):432-43. PubMed ID: 16358398
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor exon 11+/- is expressed in Zucker (fa/fa) rats, and chlorogenic acid modifies their plasma insulin and liver protein and DNA.
Rodriguez de Sotillo DV; Hadley M; Sotillo JE
J Nutr Biochem; 2006 Jan; 17(1):63-71. PubMed ID: 16169204
[TBL] [Abstract][Full Text] [Related]
19. Improved glucose tolerance by acute vanadate but not by selenate exposure in genetically obese rats (fa/fa).
Fürnsinn C; Leitner G; Roden M; Osterode W; Waldhäusl W
Int J Obes Relat Metab Disord; 1995 Jul; 19(7):458-63. PubMed ID: 8520634
[TBL] [Abstract][Full Text] [Related]
20. Modulation by glucose of insulin secretion and glucose phosphorylating activity in cultured pancreatic islets from obese (fa/fa) Zucker rats.
Chan CB; Lowe JM; Debertin WJ
Int J Obes Relat Metab Disord; 1996 Feb; 20(2):175-84. PubMed ID: 8646255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
